A detailed history of Blue Path Capital Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 389 shares of TMO stock, worth $204,641. This represents 0.15% of its overall portfolio holdings.

Number of Shares
389
Previous 378 2.91%
Holding current value
$204,641
Previous $209 Million 15.11%
% of portfolio
0.15%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$531.86 - $624.21 $5,850 - $6,866
11 Added 2.91%
389 $241 Million
Q2 2024

Aug 05, 2024

SELL
$541.52 - $599.02 $27,076 - $29,951
-50 Reduced 11.68%
378 $209 Million
Q1 2024

Apr 19, 2024

BUY
$528.82 - $599.43 $30,671 - $34,766
58 Added 15.68%
428 $249 Million
Q4 2023

Jan 11, 2024

BUY
$431.41 - $532.94 $22,001 - $27,179
51 Added 15.99%
370 $201 Million
Q3 2023

Oct 25, 2023

BUY
$498.29 - $574.41 $158,954 - $183,236
319 New
319 $161 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Blue Path Capital Management, LLC Portfolio

Follow Blue Path Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Path Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Path Capital Management, LLC with notifications on news.